KILL Molecular Targeting Technologies, Inc. Initiates Legal Action Over Unauthorized Use of Albumin-binding Evans blue (EB) Targeted Radiotherapeutic (EB-TRT)

October 11, 2025 at 15:22 PM EDT

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Molecular Targeting Technologies, Inc. requests that their press release NewsItemId: 20251013226693 issued Oct 10, 2025 “Molecular Targeting Technologies, Inc. Initiates Legal Action Over Unauthorized Use of Albumin-binding Evans blue (EB) Targeted Radiotherapeutic (EB-TRT)” be killed.

The release was issued prematurely by Molecular Targeting Technologies, Inc.

A replacement release will be reissued on Tuesday, Oct. 14th.

Contacts

Chris Pak, Email: cpak@mtarget.com

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Symbol	Price	Change (%)
AMZN	245.22	+0.00 (0.00%)
AAPL	301.54	+0.00 (0.00%)
AMD	490.33	+0.00 (0.00%)
BAC	53.63	+0.00 (0.00%)
GOOG	361.17	+0.00 (0.00%)
META	585.39	+0.00 (0.00%)
MSFT	411.74	+0.00 (0.00%)
NVDA	208.64	+0.00 (0.00%)
ORCL	211.82	+0.00 (0.00%)
TSLA	408.95	+0.00 (0.00%)

Symbol

Price

Change (%)

AMZN

245.22

+0.00 (0.00%)

AAPL

301.54

+0.00 (0.00%)

AMD

490.33

+0.00 (0.00%)

BAC

53.63

+0.00 (0.00%)

GOOG

361.17

+0.00 (0.00%)

KILL Molecular Targeting Technologies, Inc. Initiates Legal Action Over Unauthorized Use of Albumin-binding Evans blue (EB) Targeted Radiotherapeutic (EB-TRT)

Contacts

More News

Recent Quotes